Vol. 6 (11) pp. 990-996 DOI: 10.21474/IJAR01/8086

AWARENESS AND UTILIZATION OF CANCER OF CERVIX FACILITIES AMONG WOMEN: A CASE STUDY OF LURAMBI KAKAMEGA COUNTY, KENYA.

  • County Health Office, Department of Health, Kakamega County, Kenya.
  • School of Nursing and Midwifery/ MasindeMuliro University of Science and Technology, Kenya.
27 Downloads 168 Views
Crossref

Abstract

The study determined awareness of cancer of cervix and utilization of cancer of cervix facilities among women inKakamegaLurambi sub county. The study was a cross-section study. The target population were young women in reproductive age of 16-25 years. The sampling procedure used was a stratified random sampling and simple random sampling. A structured questionnaire and interview was used to collect data. Descriptive survey was used to present the findings of the research. The analysis showed that the major causes of late presentation of cervical cancer was significantly associated with lack of awareness on basic symptoms among women of reproductive age , lack of awareness on the predisposing factors to cervical cancer and also ignorance on importance of routine gynecological examination, therefore the study recommends provision of health education to people about the disease to include signs and symptoms and its presentation and also advise them to seek medical attention once they notice any sign or symptoms for early diagnosis and treatment. The study also recommends provision of screening facilities in every ward to enable early diagnosis and treatment.

Keywords

How to Cite This Article

Sally Jepkosgei Oronje, Ameldah Barasa, And Sharon Kosgey. (2018); AWARENESS AND UTILIZATION OF CANCER OF CERVIX FACILITIES AMONG WOMEN: A CASE STUDY OF LURAMBI KAKAMEGA COUNTY, KENYA., International Journal of Advanced Research (IJAR), 6 (11), 990-996, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/8086

Corresponding Author

Sally Jepkosgei Oronje
MASINDE MULIRO UNIVERSITY OF SCIENCE AND TECHNOLOGY

Article Analytics

References

  1. Alexander ER, EJ Dennis, HR Pratt-thomas(2006) ?possible ecologies of cancerof cervix ? journal of cancer researcher 33(6) page 1485-1495.
  2. Alliance for Cervical Cancer Prevention (ACCP). (2004). Planning and Implementing Cervical Cancer Prevention and Control Programs: A Manual for Managers Seattle; 24-28.
  3. American cancer society (2001). Cervical cancer facts and figure. American cancer society 27-28.
  4. American cancer society (2006)?cervical cancer, covering the female reproductive system; merck manual home edition.
  5. Arbyn M, Antilla A, Jordan J, Ranco G, Scherick U, Segnan N, Weanar H, Herbert A, Van karsal(2010) European guideline for quality assurance in cervical cancer screening 2nd edition summary document ? Journal of oncology 21(3) page 448-458.
  6. Austin, L.T., Ahmad, F., McNally, M.J, Stewart, D. E, (2002). Breast and Cervical Cancer in Hispanic women. Women?s Health Issues VOL. 12, NO. 3 May/June, 2002.
  7. Cancer Incidence Report 2000 ? 2002. (2006). Nairobi Cancer Registry, Kenya Medical Research Institute, Nairobi, Kenya.
  8. Cancer research campaign (2001) types of cervical cancer Http//www.cancerhelp/orgok/help/default.
  9. Chirenje M.Z, Rusakaniko S, Kirumbi L, Ngwall WE, Makula-Tlebere P, Kaggwa S, Mpanju-Shumbusho W, Makoa L. (2001). Situational analysisfor cervical cancer diagnosis and treatment in East, Centraland Southern African countries.Bulletin of the World Health Organisation2001, 79:127-132.
  10. Committee on practice Bulletins- gynaecology (2002) ACOG? practice bulletin; diagnosis and treatment of cervical carcinomas number 55(may 2002) ?journal of obstetrics and gynecology 99(5) page 855-867.
  11. Delinsky, Christopher (2006) ?cervical cancer; the basic oncolink (abamison cancer center of the university of pennsyslviareffered (2007).
  12. Denxy M. (2007) practical principals of cytopathology revised edition Chicago, American society for clinical pathology press.
  13. Dillmans, Robert Tk, Oldman , Robert O(2009) principals of cancer biotherapy 5th Diodrecht ;springer page 144.
  14. Efren J. Domingo, Ana Victoria V. Dy Echo. (2009). J GynecolOncol 20, No. 1:11-16, March 2009.
  15. Fort, V.K, Makin, M.S., Siegler, A.J., Ault, K., Rochat, R. (2011). Patient Preference and Adherence 2011:5 125?131.
  16. Fylan, F..British Journal of General Practice (1998) 48, 1509-1514.
  17. Gaddoci A. barsotti, casio S, Domen C. (2001) gynecology entomology the official journal of the interational society of gynecological entomology\ 27(8) page 597-604.
  18. Gottlieb, Nicole (2002) aprimeer on the ?benchmark? national cancer institute.
  19. International Agency for Research on Cancer. (2008). Cervical Cancer Incidence and Mortality.
  20. Jaslow D. Ranowizz CD. Solomon D. (2002). American cancer society guideline?s for early detection of cervical cancer and neoplasm and cancer journal for clinician 52(6) page 342-362.
  21. Joner NB, Mercer G.? lewis JL, Robin Jc. (2008) ?early invasive carcinoma of the cervix page 26-32.
  22. Kenya National Cancer Control Strategy. (2011-2016). Ministry of Public Health and Sanitation, 2011.
  23. Kumar v. Abbas AK. Fooston N. mitchelle RN. (2007) ?Basic pathology (8th edition) page 718-721.
  24. Mederos LR. Rova, Da Rosa, Bossetti, zanizz (2009) ?efficacy of human pappiloma virus; internal journal of gynecological canver 19(7) page 1166-1176.
  25. Miller AB. Shon-zheng, Sherman GJ. ?Optimizing the number of test and test intervals for cervical screening in Canada J. epidermal community health (2004).
  26. Mojer VX. (2012) screening of the cervical cancer ?un preventive services task force recommendation statement ;annual internal medicine.
  27. Muhammad E., (2008). Cervical cancer awareness and preventive behavior among female university students in South Africa. Research Communication.
  28. Munoz N, Basch FA, herrro R C. Snider PJ,(2003) Epidemiology classification on HPV types associated with cervical cancer ?medical journal 34(6) page 518-527.
  29. Nanda, Rita(2006) ?CERVICAL CANCER ? medlineplus medical encyclopedia ; national institute of health. Retrieved (2007).
  30. National Cancer Control Prevention Strategic Plan. (2012-2015). Nairobi: Government of Kenya, Ministry of Health.
  31. National cancer institute (2012) august 17th ) volume 9, no 16 ttp//www.cancer.go(2008).
  32. National Reproductive Health Strategy. (1997 ?2010). Nairobi: Government of Kenya, Ministry of Health.
  33. Payne N. chilcott J. Mcgoogan E. (2000) liquid based cytology in cervical screening; rapid and systematic review ?ill health technology assessment journal 4(18) page 1-73.
  34. Remschmidt J. kastman, andrease M. Elena. M, witchman(2003) risk factors for cervical human papilloma virus and infection and high grade intraepithelial lesion in woman aged 20-30 years in Germany ?international journal of gynecological cancer 23(3) page 519-526.
  35. Salslow D. Solomon D. Lawson, killacky, kaasingam K. Garcia. F. wentzerman (2012) American cancer society for colposcopy and cervical pathology and American society for clinical pathology screening quidelines for the prevention and early detection of cervical cancer journal.
  36. Snider PJ. Sleen Bergen RD. Herderman D.A MryerCJ.(2009) HPV ?medicated cervical carcinogenesis; concepts and clinical implication pathology journal(2009) page 152-164.
  37. Surveillance Epidemiology and End Results. (2009). Cancer Statistics Review, Vintage 2009 Populations.
  38. G.O, (2006), Knowledge, attitude and practice of Cervical Cancer Screening among female nurses in NNEWI, South Eastern Nigeria. Nigeria Journal of clinal practice. June 2006, Vol 9 (1) : 40-43.
  39. m Jacobs M. manos MM. (2000) Human papilloma virus is necessary causes of invasive cervical cancer worldwide. Journal of pathology 189(1) page 12-19.
  40. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre), (2010). Human Papillomavirus and Related cancers in Kenya - Summary Report.
  41. World health organization (2004) national cancer control program policies and management. General WHO.
  42. World health organization (2009) guidelines of cervical screening. General WHO.